SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001745020-21-000001
Filing Date
2021-02-04
Accepted
2021-02-04 11:27:09
Documents
1
Effectiveness Date
2021-02-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7323
  Complete submission text file 0001745020-21-000001.txt   8435
Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE., FL 54 NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE., FL 54 NEW YORK NY 10022 2127396493
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-315789 | Film No.: 21589736